View Author
wound healing ulcer otr 4120 treatment rgta otr 4120 collagen control treatment strength wound healing caruelle jp tissue 4120-treated otr 4120-treated ulcers effect sulfate heparan otr 4120 group growth barritault factor signi heat provocation collagen type i caruelle diabetes otr 4120-treated rats control groups study signi ficant difference repair matrix heparan sulfates signi ficant differences 6 sem animal matrix therapy activity full-thicknes ficantly excisional provocation dextran full-thickness excisional wounds analysis control rats protein signi ficantly fication weight wound closure rate collagen type iii heparan sulfate glycosaminoglycan control ulcers october content muscle response growth factors compression release tgf-b heating type iii difference ficant heparan sulfate kern p otr 4120-treated groups heparan sulfate proteoglycans bene ficial effects van neck jw 33 1 c otr 4120-treated ulcer regeneration ulcer healing fig magni homogenate cutaneous wound healing hs-gag
2 Most Recent Publications
|
Diabetes-impaired wound healing is improved by matrix therapy with heparan sulfate glycosaminoglycan mimetic OTR4120 in rats
(Article)
Tong, M. Tuk, B. Shang, P. Hekking, I.J.M. Fijneman, E.M.G. Guijt, M. Hovius, S.E.R. Neck, J.W. van |
2012-10-01
|
|
RGTA OTR 4120, a heparan sulfate proteoglycan mimetic, increases wound breaking strength and vasodilatory capability in healing rat full-thickness excisional wounds
(Article)
Tong, M. Zbinden, M.M. Hekking, I.J.M. Vermeij, M. Barritault, D. Neck, J.W. van |
2008-03-01
|